
Natalie Lea (Ahronovitz) Silver MD
Head & Neck Oncologic Surgery, Facial Plastic Surgery
Fellow
Join to view full profile
9500 Euclid Ave A71Cleveland, OH 44195
Phone+1 216-444-8552
Dr. Silver is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kentucky College of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2010 - 2014
Georgetown University School of MedicineClass of 2009
Certifications & Licensure
OH State Medical License 2021 - 2027
FL State Medical License 2016 - 2022
TX State Medical License 2015 - 2018
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsConsensus recommendations in the management of jaw (gnathic) osteosarcoma.Matthew S Dietz, Lara E Davis, Pinki K Prasad, Shauna R Campbell, John D Reith
Cancer. 2026-03-01 - 2 citationsNeutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics.William Ang, Travis D Kerr, Ananya Kodiboyena, Cristina Valero, Joris L Vos
The Journal of Clinical Investigation. 2026-01-02 - 7 citationsTumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.Nadeem Riaz, Tyler J Alban, Robert I Haddad, Michelle Saul, Vladimir Makarov
Nature Cancer. 2026-01-01
Press Mentions
Elevated Bacteria Levels in Tumors Weaken Immune Response, Studies ShowJanuary 3rd, 2026
Cleveland Clinic Research: Bacteria in Tumors May Block Cancer ImmunotherapyJanuary 7th, 2026
Bacterial Abundance Linked to Immunotherapy Response in Head and Neck CancerJanuary 8th, 2026
Grant Support
- Reducing Intratumoral Bacteria to Enhance Anti-Tumor Immunity in Oral Squamous Cell CarcinomaCLEVELAND CLINIC LERNER COM-CWRU2026–2031
- Remodeling host immunity in oral cancer with personalized RNA nanoparticle vaccinesCLEVELAND CLINIC LERNER COM-CWRU2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









